Diagnostics firm Metabolon raises $13M in series D; is IPO next?

Featured Story

Diagnostics firm Metabolon raises $13M in series D; is IPO next?

August 29, 2011 5:39 pm by | 0 Comments

Diagnostics firm Metabolon has raised $13.1 million in a fourth round of financing and in doing so has signaled intentions to eventually pursue an initial public stock offering. Metabolon added…


Novartis litigation battle prompts changes to pharmaceutical patents from IPO

Novartis litigation battle prompts changes to pharmaceutical patents from IPO

March 7, 2014 3:57 am by | 0 Comments

MUMBAI — The Indian Patent Office (IPO) has issued new draft guidelines for pharmaceutical patents aimed at minimizing the risk of patent litigations of the kind that Swiss drugmaker Novartis…


Castlight analysis: IPO filing raises questions about the company’s sales model and LTV

Castlight analysis: IPO filing raises questions about the company’s sales model and LTV

February 17, 2014 5:41 pm by | 0 Comments

Malay Gandhi’s take on Castlight Health’s IPO registration raises some interesting points about the value of price transparency and particularly, the agreements companies have to forge to obtain it. In…



2013 a good year for Israeli life sciences IPOs

2013 a good year for Israeli life sciences IPOs

October 11, 2013 4:00 am by | 0 Comments

In early 2013, the idea that, within a few months, a discussion on IPO trends by Israeli life sciences companies on Wall Street would be held would have seemed ridiculous. But even then, it was known that the life sciences were hot items on Wall Street…


Foundation Medicine rare example of IPO success for diagnostics company

Foundation Medicine rare example of IPO success for diagnostics company

September 26, 2013 4:41 pm by | 0 Comments

The Byers family must be ready to pop a bottle of champagne. Father Blake and son Brook, both Silicon Valley venture capitalists, made early bets in Foundation Medicine, a diagnostics…


With latest $70M, Practice Fusion one of the most well-funded health IT companies

With latest $70M, Practice Fusion one of the most well-funded health IT companies

September 24, 2013 2:14 pm by | 0 Comments

Electronic medical records startup Practice Fusion raised a $70 million fourth round of funding this morning, a few months after we reported series D talks. The company’s valuation is reportedly $700…


Aerie Pharmaceuticals plans to go public

Aerie Pharmaceuticals plans to go public

September 19, 2013 4:00 pm by | 0 Comments

A small drug-development company co-founded by two Duke University professors is seeking to raise up to $57.5 million in an initial public offering of stock.
Aerie Pharmaceuticals, which is based in New Jersey and has a research-and-development facilit…


Surgical Care Affiliates files for IPO of up to $100 million

Surgical Care Affiliates files for IPO of up to $100 million

September 5, 2013 7:33 am by | 0 Comments

(Reuters) – Surgical Care Affiliates Inc, a provider of outpatient surgery facilities, filed with U.S. regulators on Thursday to raise up to $100 million in an initial public offering of its common stock.
The company had 167 ambulatory surgery centers,…



LDR Holding files for IPO, medical device maker could raise up to $69M

LDR Holding files for IPO, medical device maker could raise up to $69M

August 28, 2013 4:00 am by | 0 Comments

Austin-based medical device company LDR Holding Corp. has filed for an initial public stock offering, which could raise up to $69 million, according to documents filed with the U.S. Securities and Exchange Commission.
The company designs and sells surg…


Shares fell for Cardio3 after questions on heart drug research raised in article

Shares fell for Cardio3 after questions on heart drug research raised in article

July 9, 2013 6:48 am by | 0 Comments

BRUSSELS (Reuters) – Newly listed heart drug firm Cardio3 said on Tuesday that questions raised in Forbes magazine over research on its leading product were unfounded.
The article, published online late on Monday, said a group of doctors had questioned…


Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

May 22, 2013 8:52 am by | 0 Comments

(Reuters) – Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.
Pfizer, the largest drugmaker, sold Zoetis…


Pfizer’s Zoetis IPO is the biggest since Facebook went public

Pfizer’s Zoetis IPO is the biggest since Facebook went public

February 1, 2013 9:58 am by | 0 Comments

Pfizer had a fantastic week with the successful initial public offering of its animal health unit. The IPO raised $2.2 billion and shares closed at $31.01 Friday.


Private equity group considerss Abu Dhabi healthcare IPO in 2013

Private equity group considerss Abu Dhabi healthcare IPO in 2013

December 19, 2012 9:40 am by | 0 Comments

DUBAI (Reuters) – The private equity consortium which owns half of Abu Dhabi healthcare provider Al Noor Medical is reviving plans to sell its stake through a stock market listing in 2013, four sources aware of the matter said.
The group, including Du…


Founder lists lessons learned from a failed IPO

Founder lists lessons learned from a failed IPO

November 10, 2012 2:30 pm by | 0 Comments

After being delisted from the NASDAQ, Varsity Books pivoted to preserve the business. See what else the co-founder learned from his initial failure.


Kidney protection device firm to raise $21.2M in Australian public offering

Kidney protection device firm to raise $21.2M in Australian public offering

March 8, 2012 10:42 am by | 0 Comments

A Minnesota medical device company whose products prevent kidneys from being affected from routine procedures related to angioplasty and stenting announced Thursday that it plans to raise more than $20…


N.C. diagnostics firm LipoScience files for $86M IPO

N.C. diagnostics firm LipoScience files for $86M IPO

June 24, 2011 10:27 am by | 0 Comments

Diagnostics company LipoScience aims to become North Carolina’s next public company. Raleigh, North Carolina-based LipoScience has filed with securities regulators plans to raise up to $86.2 million in an initial…